Embecta Corp (JX7)

Overview

Embecta Corp. stands as a pioneering medical device company with its focus sharply attuned to enhancing the health and wellbeing of individuals battling diabetes. With its roots planted as far back as 1924, Embecta has burgeoned into a flagship enterprise, dedicated to delivering innovative solutions for diabetes management. Operating from its headquarters in Parsippany, New Jersey, the company has marked its presence both in the United States and on an international spectrum, predominantly through wholesalers and distributors. The essence of Embecta's mission revolves around its commitment to supporting people with diabetes through its extensive range of products and digital applications designed for efficacious diabetes management.

Products and Services

• Pen Needles

Pen needles from Embecta are tailored for ease of use and comfort, meeting the diverse needs of individuals requiring insulin or other injectable diabetes medications. These needles are designed to facilitate a less painful insertion process, enhancing the overall experience of daily diabetes management.

• Syringes

Embecta presents a range of syringes geared towards ensuring accuracy, safety, and comfort during insulin delivery. These syringes are constructed with patient safety in mind, incorporating features that aim to minimize injection-related anxiety and complications.

• Safety Injection Devices

The company's Safety Injection Devices are developed with cutting-edge technology to mitigate the risks associated with needlestick injuries, a concern for both healthcare providers and patients. These devices embody the essence of Embecta's commitment to safety in diabetes care.

• Digital Applications

Recognizing the growing need for digital health solutions, Embecta has ventured into providing digital applications designed to assist individuals in managing their diabetes more effectively. These applications offer tools for monitoring blood sugar levels, medication tracking, and personalized insights into one’s diabetes management plan, ultimately aiming to empower users with control over their health.